UiPath Launches Agentic AI Solutions to Break Administrative & Financial Bottlenecks for Clinicians and Healthcare Admins

Offerings for medical records summarization, claim denial prevention and resolution, and prior authorization streamline payer/provider collaboration and dramatically reduce processing and payment delays

Visit UiPath at ViVE 2026 in booth #1212

UiPath (NYSE: PATH), a global leader in agentic automation, today announced new agentic AI solutions for the healthcare industry for providers and payers at the ViVE 2026 conference. The offerings for medical records summarization, claim denial prevention and resolution, and prior authorization leverage agentic automation, business orchestration, and purpose-built, fully compliant and governed agents to connect data, improve efficiency, and accelerate revenue cycle management.

Healthcare organizations continue to face data and information management challenges. Labor shortages and outdated, disconnected systems create friction between payers and providers. This is especially clear in revenue cycle management, where providers generate vast volumes of complex clinical documentation that must be quickly transformed into decision-ready intelligence, bridging clinical documentation with the standardized data payers need to process reimbursement accurately. When clinical data is structured and actionable, providers provide timely care and dramatically reduce accounts receivable and write-offs, while payers protect payment accuracy and integrity.

The new suite of UiPath solutions for healthcare organizations delivers end-to-end, technology-enabled outsourced revenue cycle management services. Initial solutions include:

  • Medical Records Summarization (MRS) – Converts complex, fragmented medical records into concise, citation-backed summaries, dramatically reducing review time, accelerating clinical actions, and improving patient, provider, and payer experience.
  • Claim Denial Prevention and Resolution – Reduces medical denials and write-offs by automatically detecting root causes, triggering corrective actions, and orchestrating appeals to protect revenue and tighten compliance.
  • Prior Authorization – Cuts the administrative burden by automating eligibility and benefits validation, mapping clinical data to medical-necessity rules, routing requests for review based on complexity, and providing real-time status updates to providers.​

"Since implementing the UiPath MRS solution, we've reduced the average summary review time from 70 minutes to six, a 90 percent improvement. Our clinicians are spending more time on direct patient care and less time digging through documentation. The structured output and citations give us confidence in what we're reviewing," said Benjamin Smith, Vice President of Technology, medlitix.

"As an organization, we are moving down the path of the deployment of intelligent automation across the board," said Biju Samkutty, Chief Operating Officer, International & Enterprise Automation, Mayo Clinic. "This was a fundamental decision to accelerate the transformation and the change we need to occur, allowing us to apply capabilities that are not inherent in healthcare the way we see it today. We're focused on technologies, platforms, and other ways to augment the work and reduce the administrative burden for our clinicians and staff so that they can do what they do best—care for patients and support them accordingly."

UiPath is collaborating with healthcare innovators to incorporate deep domain expertise into the UiPath agentic automation platform. For this launch, UiPath is partnering with Genzeon—an AI-powered healthcare automation company and one of only six technology vendors selected by CMS for the Wasteful and Inappropriate Service Reduction (WISeR) Model—to deliver the prior authorization solution. Founded in 2012, Genzeon brings deep payer expertise across more than 100 healthcare clients, 30+ disease-specific clinical models, and audit-grade compliance frameworks purpose-built for regulated environments.

"The opportunity for agentic transformation in healthcare is huge, and the stakes could not be any higher," said Graham Sheldon, Chief Product Officer, UiPath. "Labor challenges, rising costs, increasing and complex regulations… all of these are a catalyst for fundamental change to the ultimate benefits of payers, providers, and patients. Our new agentic automation and orchestration offerings connect data across the enterprise, accelerate critical workflows, and remove the costly, time-consuming errors that create friction and delay results."

For more on the new UiPath solutions for healthcare, visit UiPath at the ViVE 2026 Conference in booth #1212 or click here .

About UiPath

UiPath (NYSE: PATH) is a global leader in business orchestration and automation, empowering enterprises to harness the full potential of AI agents to autonomously execute and optimize complex business processes. The UiPath Platform™ uniquely combines controlled agency, developer flexibility, and seamless integration to help organizations scale agentic automation safely and confidently. Committed to security, governance, and interoperability, UiPath supports enterprises as they transition into a future where automation delivers on the full potential of AI to transform industries. For more information, visit http://www.uipath.com .

Media Contact
Christian Potts for UiPath
pr@uipath.com

Investor Relations Contact
Allise Furlani for UiPath
investor.relations@uipath.com

News Provided by Business Wire via QuoteMedia

PATH
The Conversation (0)
Electric Royalties Provides Update on Critical Metals Royalty Portfolio

Electric Royalties Provides Update on Critical Metals Royalty Portfolio

Electric Royalties Ltd. (TSXV:ELEC)(OTCQB:ELECF) ("Electric Royalties" or the "Company") is pleased to provide an update on key assets within its royalty portfolio based on public disclosures made by project operators between December 8, 2025, and March 25, 2026."With copper royalty revenue from... Keep Reading...
Independent CTRI Testing Indicates RZOLV Exhibits Dramatically Lower Acute Trout Toxicity Than Cyanide Reference

Independent CTRI Testing Indicates RZOLV Exhibits Dramatically Lower Acute Trout Toxicity Than Cyanide Reference

Rzolv Technologies Inc. (TSXV: RZL,OTC:RZOLF) (OTCQB: RZOLF) ("RZOLV" or the "Company") today announced the results of an ecotoxicity report prepared by Centre Technologique des Résidus Industriels ("CTRI"), a recognized leader in environmental technologies and ecotoxicology, which evaluated the... Keep Reading...
Altona (LSE: REE)

Final Assay Results Confirm High-Grade, Near-Surface Fluorspar and Gallium Mineralisation at Monte Muambe

Altona (LSE: REE), a resource exploration and development company focused on critical raw materials in Africa, is pleased to announce the receipt of all outstanding assay results from its 2025 drilling campaign at Monte Muambe.HighlightsAll assays received: Final results from the 2025 drilling... Keep Reading...
Laurion 2026 Strategic Update For Ishkoday: Proposed Dual-Drill Program, Stockpile Gold Recovery Initiative, And Phased Path To Mineral Resource Estimate

Laurion 2026 Strategic Update For Ishkoday: Proposed Dual-Drill Program, Stockpile Gold Recovery Initiative, And Phased Path To Mineral Resource Estimate

Toronto, Ontario — March 24, 2026 TheNewswire — Laurion Mineral Exploration Inc. (TSX-V: LME | OTCQB: LMEFF | FSE: 5YD) ("LAURION" or the "Company") is pleased to announce its 2026 strategic work program at the Ishkōday Gold Project ("Ishkōday" or the "Property"), located 220 kilometres... Keep Reading...

Interactive Chart

Latest Press Releases

Related News